Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian D Marsden

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Nature Communications|October 30, 2021
Anti-spike antibody response to natural SARS-CoV-2 infection in the general populationJia Wei, Philippa C Matthews, Nicole Stoesser, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2013
Structures of ABCB10, a human ATP-binding cassette transporter in apo- and nucleotide-bound statesChitra A Shintre, Ashley C W Pike, Qiuhong Li, et al.
Nature Microbiology|July 22, 2021
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United KingdomJia Wei, Nicole Stoesser, Philippa C Matthews, et al.
Nature Communications|June 24, 2024
Improving the representativeness of UK's national COVID-19 Infection Survey through spatio-temporal regression and post-stratificationKoen B Pouwels, David W Eyre, Thomas House, et al.
Journal of Epidemiology and Community Health|November 3, 2023
Persistence of SARS-CoV-2 antibodies over 18 months following infection: UK Biobank COVID-19 Serology StudyJelena Bešević, Ben Lacey, Howard Callen, et al.
Nature Communications|July 4, 2024
A data science roadmap for open science organizations engaged in early-stage drug discoveryKristina Edfeldt, Aled M Edwards, Ola Engkvist, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 10, 2021
Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection statusDavid W Eyre, Sheila F Lumley, Jia Wei, et al.
Structure (London, England : 1993)|June 25, 2013
Crystal structures of malonyl-coenzyme A decarboxylase provide insights into its catalytic mechanism and disease-causing mutationsD Sean Froese, Farhad Forouhar, Timothy H Tran, et al.
Nature Genetics|June 30, 2019
A genetics-led approach defines the drug target landscape of 30 immune-related traitsHai Fang, , Hans De Wolf, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2021
The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare WorkersSheila F Lumley, Jia Wei, Denise O'Donnell, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Nature Communications|October 30, 2021
Anti-spike antibody response to natural SARS-CoV-2 infection in the general populationJia Wei, Philippa C Matthews, Nicole Stoesser, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2013
Structures of ABCB10, a human ATP-binding cassette transporter in apo- and nucleotide-bound statesChitra A Shintre, Ashley C W Pike, Qiuhong Li, et al.
Nature Microbiology|July 22, 2021
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United KingdomJia Wei, Nicole Stoesser, Philippa C Matthews, et al.
Nature Communications|June 24, 2024
Improving the representativeness of UK's national COVID-19 Infection Survey through spatio-temporal regression and post-stratificationKoen B Pouwels, David W Eyre, Thomas House, et al.
Journal of Epidemiology and Community Health|November 3, 2023
Persistence of SARS-CoV-2 antibodies over 18 months following infection: UK Biobank COVID-19 Serology StudyJelena Bešević, Ben Lacey, Howard Callen, et al.
Nature Communications|July 4, 2024
A data science roadmap for open science organizations engaged in early-stage drug discoveryKristina Edfeldt, Aled M Edwards, Ola Engkvist, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 10, 2021
Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection statusDavid W Eyre, Sheila F Lumley, Jia Wei, et al.
Structure (London, England : 1993)|June 25, 2013
Crystal structures of malonyl-coenzyme A decarboxylase provide insights into its catalytic mechanism and disease-causing mutationsD Sean Froese, Farhad Forouhar, Timothy H Tran, et al.
Nature Genetics|June 30, 2019
A genetics-led approach defines the drug target landscape of 30 immune-related traitsHai Fang, , Hans De Wolf, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2021
The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare WorkersSheila F Lumley, Jia Wei, Denise O'Donnell, et al.
Pageof 7